Investors Sell Shares of Morgan Stanley (MS) on Strength (MS)

Traders sold shares of Morgan Stanley (NYSE:MS) on strength during trading on Wednesday. $64.70 million flowed into the stock on the tick-up and $83.93 million flowed out of the stock on the tick-down, for a money net flow of $19.23 million out of the stock. Of all equities tracked, Morgan Stanley had the 28th highest net out-flow for the day. Morgan Stanley traded up $0.04 for the day and closed at $55.10

A number of brokerages have issued reports on MS. Atlantic Securities upgraded Morgan Stanley from a “neutral” rating to an “overweight” rating and set a $61.00 price objective for the company in a research note on Wednesday, January 10th. UBS Group upgraded Morgan Stanley to an “overweight” rating in a research note on Wednesday, January 10th. Credit Suisse Group upgraded Morgan Stanley to a “buy” rating and set a $58.00 price objective for the company in a research note on Thursday, January 4th. Societe Generale set a $61.00 price objective on Morgan Stanley and gave the company a “neutral” rating in a research note on Monday, January 22nd. Finally, Royal Bank of Canada restated a “buy” rating and issued a $60.00 price objective on shares of Morgan Stanley in a research note on Friday, January 19th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $54.07.

The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 2.68. The stock has a market capitalization of $99,620.00, a PE ratio of 14.65, a P/E/G ratio of 0.95 and a beta of 1.54.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings results on Thursday, January 18th. The financial services provider reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.03% and a net margin of 14.10%. The firm had revenue of $9.50 billion for the quarter, compared to analysts’ expectations of $9.25 billion. During the same quarter in the prior year, the firm earned $0.81 EPS. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. equities analysts forecast that Morgan Stanley will post 4.51 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Stockholders of record on Wednesday, January 31st were given a dividend of $0.25 per share. The ex-dividend date was Tuesday, January 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.81%. Morgan Stanley’s dividend payout ratio is presently 26.60%.

In related news, Director Alistair Darling sold 3,850 shares of the stock in a transaction dated Friday, November 24th. The stock was sold at an average price of $49.29, for a total transaction of $189,766.50. Following the sale, the director now owns 14,218 shares of the company’s stock, valued at approximately $700,805.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jonathan Pruzan sold 52,204 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $55.35, for a total value of $2,889,491.40. The disclosure for this sale can be found here. Insiders have sold a total of 268,104 shares of company stock worth $14,524,785 in the last three months. 0.24% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently modified their holdings of the stock. Exane Derivatives raised its holdings in shares of Morgan Stanley by 303.9% in the 4th quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after acquiring an additional 1,489 shares in the last quarter. Invictus RG raised its holdings in shares of Morgan Stanley by 307.5% in the 3rd quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock valued at $112,000 after acquiring an additional 1,762 shares in the last quarter. Rational Advisors LLC purchased a new stake in shares of Morgan Stanley in the 3rd quarter valued at about $116,000. Zions Bancorporation raised its holdings in shares of Morgan Stanley by 176.1% in the 3rd quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock valued at $119,000 after acquiring an additional 1,571 shares in the last quarter. Finally, First Dallas Securities Inc. purchased a new stake in shares of Morgan Stanley in the 4th quarter valued at about $121,000. 86.32% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Investors Sell Shares of Morgan Stanley (MS) on Strength (MS)” was reported by Week Herald and is the property of of Week Herald. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://weekherald.com/2018/02/21/investors-sell-shares-of-morgan-stanley-ms-on-strength-ms.html.

About Morgan Stanley

Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply